argenx SE Share Price
NASDAQ: ARGXargenx SE Stock Performance
argenx SE Share Price Today
As of 29 October 2026, argenx SE's share price is $899.25. The stock opened at $896.46, compared to its previous close of $890.93. During today's trading session, argenx SE's share price traded between $894.65 and $903.86, with an average price of $899.25. Over the past 52 weeks, the stock has recorded a high of $1,072.33 and a low of $662.47. In terms of performance, argenx SE's share price has risen by 15.03% over the last six months and is up 9.61% on a year-on-year basis.
argenx SE Share Price Chart
About argenx SE
Argenx is a Dutch biopharmaceutical company focused on developing antibody-based therapies for rare autoimmune diseases. The company's lead product, Vyvgart (efgartigimod), was approved by the FDA in December 2021 for the treatment of generalized myasthenia gravis (gMG). In 2022, Argenx also received FDA approval for Vyvgart Hytrulo, a subcutaneous formulation of Vyvgart, offering a more convenient option compared with Vyvgart's intravenous administration. In 2024, the FDA approved Vyvgart Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy, a rare immune-mediated neuromuscular disorder of the peripheral nervous system. Argenx is focused on innovation and developing its pipeline for treatments such as primary immune thrombocytopenia, thyroid eye disease, and Sjogren's Disease.
argenx SE Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $957.31 | $899.08 | -6.24% |
Sep 2026 | $1,036.20 | $958.89 | -9.44% |
Aug 2026 | $841.89 | $1,058.90 | +24.10% |
Jul 2026 | $929.48 | $853.24 | -8.16% |
Jun 2026 | $833.33 | $929.08 | +11.15% |
May 2026 | $782.86 | $835.85 | +6.92% |
Apr 2026 | $740.77 | $781.78 | +7.01% |
Mar 2026 | $759.49 | $730.60 | -4.71% |
Feb 2026 | $844.74 | $766.68 | -8.81% |
Jan 2026 | $843.86 | $840.71 | -0.06% |
Dec 2025 | $903.43 | $841.25 | -7.72% |
Nov 2025 | $817.40 | $911.60 | +11.11% |